Efficacy and safety of catheter ablation for Brugada syndrome: an updated systematic review.

ABSTRACT:

Background

Patients with Brugada syndrome (BrS) may experience recurrent ventricular arrhythmias (VAs). Catheter ablation is becoming an emerging paradigm for treatment of BrS.

Objective

To assess the efficacy and safety of catheter ablation in BrS in an updated systematic review.

Methods

We comprehensively searched the databases of Pubmed/Medline, EMBASE, and Cochrane Central Register of Controlled Trials from inception to 11th of August 2021.

Results

Fifty-six studies involving 388 patients were included. A substrate-based strategy was used in 338 cases (87%), and a strategy of targeting premature ventricular complex (PVCs)/ventricular tachycardias (VTs) that triggered ventricular fibrillation (VF) in 47 cases (12%), with combined abnormal electrogram and PVC

SUBMITTER: Kotake Y 

PROVIDER: S-EPMC10698106 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature